During the clinical trial, the observed side effects were mainly gastrointestinal, such as nausea and vomiting
(NewsNation) A new experimental weight loss drug that targets three hormones simultaneously may outperform Ozempic and Mounjaro, but patients need close medical supervision to use it safely, a regenerative medicine physician said
Semaglutide, the drug in Ozempic and Wegovy, is a GLP-1R agonist only
Possible concerns may include nausea, vomiting, diarrhea, constipation, appetite suppression, dehydration, fatigue, gallbladder concerns, blood sugar changes, excessive weight loss, and loss of lean muscle if weight drops too quickly
(July 2014)
Our commitment lies in delivering personalized care and support, with a constant focus on ensuring our patients health and well-being